Page last updated: 2024-08-25
mitozolomide and Skin Neoplasms
mitozolomide has been researched along with Skin Neoplasms in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Breistøl, K; Fodstad, O; Kjønniksen, I | 1 |
Aamdal, S; Fodstad, O; Gundersen, S | 1 |
Other Studies
2 other study(ies) available for mitozolomide and Skin Neoplasms
Article | Year |
---|---|
Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Neoplasms; Cisplatin; Dacarbazine; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Melanoma; Nitrogen Mustard Compounds; Rats; Rats, Nude; Skin Neoplasms; Transplantation, Heterologous | 1992 |
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Drug Evaluation; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Skin Neoplasms | 1987 |